31st Mar 2014 2:00 pm |
RNS |
Director/PDMR Shareholding |
31st Mar 2014 2:00 pm |
RNS |
Director/PDMR Shareholding |
31st Mar 2014 2:00 pm |
RNS |
Director/PDMR Shareholding |
26th Mar 2014 11:00 am |
RNS |
Director/PDMR Shareholding |
21st Mar 2014 7:00 am |
RNS |
Filing of Annual Report on Form 20-F with SEC |
20th Mar 2014 11:00 am |
RNS |
Annual Financial Report |
20th Mar 2014 11:00 am |
RNS |
Directorate Change |
19th Mar 2014 3:00 pm |
RNS |
Director/PDMR Shareholding |
12th Mar 2014 7:00 am |
RNS |
AstraZeneca announces sale of Alderley Park site |
3rd Mar 2014 4:00 pm |
RNS |
Total Voting Rights |
3rd Mar 2014 7:00 am |
RNS |
US FDA APPROVES BYDUREON® PEN |
25th Feb 2014 6:24 pm |
RNS |
FDA Approves Orphan Drug Myalept |
12th Feb 2014 3:30 pm |
RNS |
Director/PDMR Shareholding |
11th Feb 2014 5:00 pm |
RNS |
Director/PDMR Shareholding |
10th Feb 2014 5:30 pm |
RNS |
Director/PDMR Shareholding |
7th Feb 2014 3:30 pm |
RNS |
Director/PDMR Shareholding |
6th Feb 2014 7:00 am |
RNS |
Pipeline Table |
6th Feb 2014 7:00 am |
RNS |
Final Results |
5th Feb 2014 9:00 am |
RNS |
Notice of Results |
3rd Feb 2014 4:30 pm |
RNS |
Total Voting Rights |
3rd Feb 2014 7:00 am |
RNS |
AZ completes BMS diabetes acquisition |
27th Jan 2014 10:30 am |
RNS |
Holding(s) in Company |
22nd Jan 2014 7:00 am |
RNS |
Xigduo approved in EU for type 2 diabetes |
17th Jan 2014 10:42 am |
RNS |
Replacement re block listing application |
17th Jan 2014 7:00 am |
RNS |
Block Listing Application |
14th Jan 2014 7:00 am |
RNS |
AstraZeneca provides strategy update at JP Morgan |
13th Jan 2014 7:00 am |
RNS |
US FDA APPROVES FARXIGAT (DAPAGLIFLOZIN) |
9th Jan 2014 7:00 am |
RNS |
US FDA Approval of Farxiga (dapagliflozin) |
2nd Jan 2014 4:00 pm |
RNS |
Total Voting Rights |
27th Dec 2013 7:13 am |
RNS |
AZ and Shionogi extend Crestor agreement |
19th Dec 2013 2:00 pm |
RNS |
Director/PDMR Shareholding |
19th Dec 2013 7:50 am |
RNS |
AZ to acquire BMS share of diabetes assets |
17th Dec 2013 6:13 pm |
RNS |
STATEMENT ON ESOMEPRAZOLE STRONTIUM LAUNCH IN US |
13th Dec 2013 7:14 am |
RNS |
Top Line Results From Phase III Study of Lesinurad |
13th Dec 2013 7:00 am |
RNS |
FDA Advisory Committee Recommends Dapagliflozin |
12th Dec 2013 7:00 am |
RNS |
FDA Advisory Committee Votes on Metreleptin |
6th Dec 2013 7:00 am |
RNS |
European Commission Approves Fluenz Tetra |
2nd Dec 2013 3:00 pm |
RNS |
Blocklisting Interim Review |
22nd Nov 2013 1:42 pm |
RNS |
XIGDUO POSITIVE CHMP OPINION FOR TYPE 2 DIABETES |
19th Nov 2013 7:00 am |
RNS |
NDA for Naloxegol accepted by US FDA |